can you really do this in primary care? – the da vinci project · da vinci: the medical visit •...
TRANSCRIPT
Can you really do this in primary care? – The DA VINCI Project Dr. Nadeem Akhtar Brad LaForme MBBS (Lond),MA (Cantab), MRCPsych(UK) MSW RSW Dr. Jehaan Illyas Katie Davidman MD, F.R.C.P.C. MSW RSW
PRESENTER DISCLOSURE
• Presenter: Nadeem Akhtar MA (Cantab), MBBS (Lond), MRCPsych (UK) Assistant Professor, Department of Psychiatry, McMaster University Staff Psychiatrist, Hamilton Family Health Team
• Relationships with commercial interests: – Grants/Research Support: none – Speakers Bureau/Honoraria: none – Consulting Fees: none – Other: none
Department of Family Medicine
Department of Psychiatry
PRESENTER DISCLOSURE
Department of Family Medicine
Department of Psychiatry
• Presenter: Dr. A. Jehaan Illyas M.D., F.R.C.P.C.
• Relationships with commercial interests:
– Grants/Research Support: None – Speakers Bureau/Honoraria: Sunovion, Allergan – Consulting Fees: Sunovion, Allergan, Lundbeck – Other: None
PRESENTER DISCLOSURE
• Presenters: Brad LaForme MSW RSW
Katie Davidman MSW RSW
• Relationships with commercial interests:
– Grants/Research Support: None
– Speakers Bureau/Honoraria: None
– Consulting Fees: None
– Other: None
Department of Family Medicine
Department of Psychiatry
LEARNING OBJECTIVES
Department of Family Medicine
Department of Psychiatry
1) Describe an Integrated Care Pathway (ICP) for treating major depression and alcohol use disorders concurrently, and how to make it fit for primary care.
2) Describe how collaboration between all clinical parties, (Family Physician, Psychiatry,
Mental Health, Pharmacy, and Nutrition) were developed, refined, and organized for improved patient care.
3) Describe how technology was utilized for ongoing patient screening/assessment and
how this data informed medication changes when indicated by the algorithm.
“Can you really do this in
primary care?”
The core elements of the pathway include: measurement-based care, pharmacological and psychotherapeutic interventions, and a clinical workflow that incorporates an
inter-professional team.
PART ONE: The Group
“We took a 16-session out-patient hospital-based program and transformed it into a 17-week primary care
psychotherapy group.”
Program Structure
o Concurrent Treatment of Major Depressive Disorder and Alcohol Use Disorder as defined by DSM V
o 17 – 2-hour weekly group psychotherapy sessions. o Pharmacological intervention via anti-depressant and anti-craving
medication. o Pre and Post group assessment tools, as well as…. o Bi-weekly screens for depression symptoms, alcohol cravings scales,
and weekly drinking results. o Bi- weekly medical visits with team psychiatrist to review screening
tools scores and adjust medication as informed by the DA VINCI anti-depressant and anti-craving medication algorithm.
DA VINCI: Psychosocial Therapy Overview
Session: 0-2
Introduction &
Motivational Enhancement
Session: 3-6
Behavioural Focus:
Behavioural Activation
Skills Building for High-Risk
Situations
Session: 7-11
Cognitive Focus:
Cognitive
Restructuring,
Maladaptive Assumptions,
Problem Solving,
Action Planning
Session: 12-13
Relapse Prevention
Lapse
Management
Session: 14-16
Comprehensive Review
Building Social
Supports
Aftercare Planning
Assessment Tools
Measures
Alcohol Use Disorders Identification Test
(AUDIT)
Enter the Pathway
Exit the Pathway
Penn Alcohol Craving Scale
(PACS)
Enter the Pathway
Biweekly
Exit the Pathway
Quick Inventory of Depressive
Symptomatology (QIDS)
Enter the Pathway
Biweekly
Exit the Pathway
Suicide Risk Assessment
Enter the Pathway
If required
Exit the Pathway
Quality of Life Scale (EQ-5D-5L)
World Health Organization Disability
Assessment Schedule (WHODAS 2.0)
Enter the Pathway
Exit the Pathway
Standardized Assessments
Ocean Tablet
Weekly Drinking Record
Session Number: 14
Date: April 19, 2017
Name: ___________________
This past week…
SDDD (Standard Drinks per Drinking Day) When you drank, how many drinks did you have on average? _____ DDW (Drinking Days per Week) How many days did you drink? _____ SSW (Standard Drinks per Week) How many drinks did you have in total? _____ HDDW (Heavy Drinking Days per Week) How many days did you have (Men: 5 or more; Women: 4 or more) _____
Patient
Group Materials
Therapeutic Modalities Cognitive Behavioural Therapy (CBT) Motivational Interviewing (MI) Structured Relapse Prevention (SRP) Dialectic Behaviour Therapy (DBT)
Referral/Screening
Role of Multidisciplinary Team
Clinical Family Doctor Psychiatrist
Dr. Nadeem Akhtar Dr. Jehaan Illyas Pharmacist
Dr. Antony Gagnon Group Therapists
Brad LaForme MSW RSW Katie Davidman MSW RSW Cynthia Forrest RN BScN CPMHN(C) Registered Dietitian
Susan Smith RD CDE
Non-Clinical Sari Ackerman Coordinator/Administrator
Jesse Lamothe Quality Improvement Decision Support Specialist
Kathy & Emily Admin/Reception
Organization Leadership Catherine McPherson-Doe Manager, Mental Health and Nutrition Programs
Dr. Lindsey George Clinical Director and Lead Psychiatrist
0
10
20
30
40
50
60
Group 1 Group 2 Combined
Pre and Post SDW
Mean pre score
Mean post score
0.0
10.0
20.0
30.0
40.0
50.0
60.0
70.0
Wk 0 Wk 2 Wk 4 Wk 6 Wk 8 Wk 10 Wk 12 Wk 14 Wk 16
SDW Bi-Weekly Scores
Group 1
Group 2
Combined
Group 1 (n=13) Group 2 (n=7) Combined (n=20)
Mean SDWs at orientation 50.2 17.1 38.6
Mean SDWs at end of treatment 30.8 1.7 20.7
Percent decrease from pre- to post-group 38.6% 90.0% 46.4%
Pre and Post Group Measures
Standard Drinks Per Week (SDW) SDW were self-reported by participants every 2 weeks from week 0 (orientation)
to week 16 (end of treatment).
Pre and Post Group Measures
Standard Drinks Per Drinking Day (SDDD) SDDD were self-reported by participants every 2 weeks from week 0 (orientation)
to week 16 (end of treatment).
Group 1 (n=13) Group 2 (n=7) Combined (n=20)
Mean SDDDs at orientation 8.7 7.1 8.2
Mean SDDDs at end of treatment 5.0 1.3 3.7
Percent decrease from pre- to post-group 42.5% 81.7% 54.9%
0
1
2
3
4
5
6
7
8
9
10
Group 1 Group 2 Combined
Pre and Post SDDD
Mean pre score
Mean post score
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
Wk 0 Wk 2 Wk 4 Wk 6 Wk 8 Wk 10 Wk 12 Wk 14 Wk 16
SDDD Bi-Weekly Scores
Group 1
Group 2
Combined
0.0
5.0
10.0
15.0
20.0
25.0
Wk 0 Wk 2 Wk 4 Wk 6 Wk 8 Wk 10 Wk 12 Wk 14 Wk 16
PACS Bi-Weekly Scores
Group 1
Group 2
Combined
0
5
10
15
20
25
Group 1 Group 2 Combined
PACS Pre and Post Scores
Mean pre score
Mean post score
Pre and Post Group Measures
Penn Anti-Craving Scale (PACS) (min=0, max=30) The PACS was administered every 2 weeks from week 0 (orientation) to week 16 (end of treatment).
Group 1 (n=13) Group 2 (n=7) Combined (n=20)
Mean score at orientation 22.9 21.4 22.4
Mean score at end of treatment 19.1 14.4 17.4
Percent decrease from pre- to post-group 16.6% 32.7% 22.3%
Pre and Post Group Measures
Quick Inventory of Depressive Symptomology (QIDS) (min=1, max=27) The QIDS was administered every 2 weeks from week 0 (orientation) to week 16 (end of treatment).
0
2
4
6
8
10
12
14
16
18
20
Group 1 Group 2 Combined
QIDS Pre and Post Scores
Mean pre score
Mean post score
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
16.0
18.0
20.0
Wk 0 Wk 2 Wk 4 Wk 6 Wk 8 Wk10
Wk12
Wk14
Wk16
QIDS Bi-Weekly Scores
Group 1
Group 2
Combined
Group 1 (n=13) Group 2 (n=7) Combined (n=20)
Mean score at orientation 16.0 17.4 16.5
Mean score at end of treatment 11.3 14.7 12.5
Percent decrease from pre- to post-group 29.4% 15.5% 24.2%
But the numbers don`t tell the whole story
More than just alcohol and depression
Other substance use Other mental health issues (anxiety)
Personality issues (BPD) Relationship issues
Trauma Physical health
Chronic pain Employment
Group Personality
Like opening Pandora's box
What does success look like?
Group Personality
DA VINCI Duckpins
“Initiating friendships with other group members outside of group is not recommended. If conflict or disagreement between group members occurs this can interfere with your comfort
level and attendance at treatment.”
DAVINCI Psychotherapy Group Workbook: Guidelines and Expectations for Group Members
Support beyond the confines of the group – a pleasant discovery!
A Patient's Story
0
20
40
60
80
100
120
14-Sep-
16
21-Sep-
16
5-Oct-16
19-Oct-
16
2-Nov-
16
16-Nov-
16
30-Nov-
16
28-Dec-
16
# Drinks per DrinkingDay
14 14 13 12 9 8 8 5
Drinking Days perWeek
7 7 7 7 7 7 7 7
Standard Drinks perWeek
98 93 87 86 66 57 61 27
0
5
10
15
20
25
30
35
7-Sep-16 21-Sep-16 5-Oct-16 19-Oct-16 16-Nov-16 28-Dec-16
PACS 17 15 12 21 19 16
QIDS 30 25 29 30 30 23
Depression & Craving Scales Drinking Scales
0
10
20
30
40
50
60
70
80
90
14-Sep-
16
5-Oct-16
19-Oct-
16
2-Nov-
16
16-Nov-
16
30-Nov-
16
14-Dec-
16
28-Dec-
16
# Drinks per DrinkingDay
12 10 10 10 8 9 10 7
Drinking Days perWeek
7 7 7 7 7 7 7 7
Standard Drinks perWeek
79 83 70 68 62 60 63 51
0
5
10
15
20
25
30
7-Sep-16
21-Sep-16
5-Oct-16
19-Oct-16
2-Nov-16
16-Nov-16
30-Nov-16
14-Dec-16
28-Dec-16
PACS 21 19 25 16 17 12 19 20 17
QIDS 7 11 10 4 10 8 8 9 9
Depression & Craving Scales Drinking Scales
A Patient's Story
Therapist and system that suits the client population Going beyond the Manual
Adapting to meet the evolving need for support
Therapist Experience
It can be exhausting!!
Before Starting – Preparation
– Psychiatric History – Medication Reconciliation
PART TWO: The Medical Visit
Before Starting – Preparation – Genetic Testing – PRIME, Pillcheck
• Done by A. Gagnon (Pharmacy) – Medical History – Laboratory Testing
DA VINCI: The Medical Visit
Before Starting – Preparation – Medical History – Laboratory Testing
• Liver function testing, CBC, Kidney Function, Urine DS • Other labs as necessary eg. TSH, Ferritin, Vitamin B12
– Other Substance History • Cannabis • Opioid Use – exclusion for Naltrexone
DA VINCI: The Medical Visit
• Week 0 Visit – Explanation of medical role to group – Questions/ Clarifications – Brief Discussion on Agents Used
• Antidepressants • Anti-Craving Drugs
DA VINCI: The Medical Visit
DA VINCI: The Medical Visit
• Weeks 2, 4, 6, 8, 10, 12, 14, 16 – Brief Medical Interview – Charting – Medication Titration – Psychosocial Stressors – Management of Comorbidities
DA VINCI: The Medical
Visit
Weeks 2, 4, 6, 8, 10, 12, 14, 16
– Algorithm: • Antidepressants
– Sertraline – Fluoxetine – Venlafaxine XR – Mirtazapine
DA VINCI: The Medical Visit
• Weeks 2, 4, 6, 8, 10, 12, 14, 16 – Algorithm:
• Anticraving – Naltrexone; Acamprosate; Topiramate
DA VINCI: The Medical Visit
• Weeks 2, 4, 6, 8, 10, 12, 14, 16 – Scales Used
• QIDS – Quick Inventory of Depressive Symptomatology Scale
• PACS – Penn Alcohol Craving Scale – Guide for Pharmacotherapy
DA VINCI: The Medical Visit
• Discharge Planning – Charting completed and sent to Primary Practice – Follow-up Planning – Aftercare:
• Community Resources • Within Family Health Team • Complex Care Referral
– Concurrent Disorders Treatment • Residential Treatment planning
– Indirect Support of Primary Practice
The HFHT DAVINCI Pilot Group Lessons Learnt
The First Session:
ORIGINAL ISSUE LESSON, CHANGES
Group medical visit vs individual review Group medical not billable. Complex cases need individualized care. Opted for brief individual review every 2 weeks.
Time Constraints. One hour for 20 patients’ psychiatric review. Two psychiatrists
Group size limited to 10 total. Review time increased to 1.5 hrs. 1 hr. paperwork prep before review.
Medical co-morbidity-impacting treatment choice
History unclear. Often complex array of diagnoses. Now opting for psych consultation at the point of acceptance of the group.
The First Session:
ORIGINAL ISSUE LESSON, CHANGES
Patient history, narrative, diagnosis History unclear. Often complex array of diagnoses. Now opting for psych consultation at the point of acceptance of the group.
Physical health/medication reconciliation
Records from family doctor, pharmacist led medication reconciliation prior to first week
Clarify opiate prescribing-impact on Naltrexone prescription
Practical issues:
ORIGINAL ISSUE LESSON, CHANGES
Not sure if coverage for medication
Acamprosate and Naltrexone cost
No clear structure for reporting to family doctor
Pharmacist reconciliation and interview Prior to first session. Compassionate access Support in linking to this
Template for initiation and discharge. Family physician to be updated at any critical change
During the Programme:
ORIGINAL ISSUE LESSON, CHANGES
Appointment expectations Issues between psychiatric review
Titration schedule
Scale scores not aligned with progress
Coverage if one psychiatrist away
Flow of information within the team
Clarify psychiatrist role from outset Delineate time limitations Facilitators go-between outside of Scheduled reviews
Individualise as per standard practice
Clinical perspective given greater weight Discuss discrepancy with pt. and facilitators
Facilitators go-between outside of Scheduled reviews. Cross coverage review In unscheduled week for urgent issues
Check in at end of group every other week, updates as they may arise
The End of the Group:
ORIGINAL ISSUE LESSON, CHANGES
For higher risk patients connect to Concurrent Disorders counselling and psychiatric review within the HFHT until care assumed by a secondary care service.
AFTERCARE
Link to Drinkwise, other HFHT groups, community resources Drop-in after-care group/?peer support group
Encourage follow-up with family physician and practice mental health counsellor
Quite the Journey… BUT it could
HAVE BEEN worse!!
Contact
Can you really do this in primary care? The DA VINCI Project
Dr. Nadeem Akhtar MBBS(Lond), MA(Cantab), MRCPsych(UK) Psychiatrist
Hamilton Family Health Team [email protected]
Brad LaForme MSW RSW
Substance Use Program Coordinator Hamilton Family Health Team
905-667-4848 ext. 146 [email protected]